"The spam message uses the Brazilian electronic invoice system, NF-e, as a lure to entice users into clicking hyperlinks and ...

Businesses are constantly seeking innovative ways to improve their customers’ experiences. Originally published in Law360 - ...

China and the United States have agreed to remove the majority of tariffs imposed since April 2, a breakthrough following high-stakes talks that could help resolve a trade war that had raised import ...

We’ve created a guide to explain how to choose a podcast hosting platform, plus a round up of the best platforms to suit your unique needs.

As Meta starts testing a new monetization drive across its social networks, Threads is launching video advertising for the ...

Islami Andolan Bangladesh (IAB) yesterday stressed the restoration of "absolute trust and faith in Almighty Allah" in place of the proposed principle of pluralism in the constitution during a ...

The news was announced at Meta’s presentation at the IAB NewFronts, where a number of social media companies pitch themselves to advertisers. On Threads, Meta says a “small number” of ...

As podcasting becomes a thoroughly mainstream medium, a new report is placing US podcast revenue at $4.7 billion – almost double the recent IAB/PwC estimate. Why the jump? It comes from consumer ...

As GLP-1 firms continue to bulk up, WeightWatchers (WW) is stepping off the scale. The points-system-based weight loss program filed for bankruptcy on May 6, with its premarket value plummeting 52 ...

A James Bond-esque mission to recover highly sensitive secret files held in safes aboard the sunken super-yacht Bayesian was reportedly carried out by UK intelligence service MI6 before Italian ...

As KZN gears up for the Soweto derby showdown at Moses Mabhida Stadium today, law enforcement authorities say they are ready to ensure safety and order, despite a ticketing fiasco that has left ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...